Show simple item record

Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-Α production in keratinocytes cultured from psoriatic lesions

dc.contributor.authorNickoloff, Brian J.en_US
dc.contributor.authorMitra, R. S.en_US
dc.contributor.authorElder, J. T.en_US
dc.contributor.authorFisher, G. J.en_US
dc.contributor.authorVoorhees, John J.en_US
dc.date.accessioned2010-06-01T21:10:51Z
dc.date.available2010-06-01T21:10:51Z
dc.date.issued1989-08en_US
dc.identifier.citationNICKOLOFF, B.J.; MITRA, R.S.; ELDER, J.T.; FISHER, G.J.; VOORHEES, J.J. (1989). "Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-Α production in keratinocytes cultured from psoriatic lesions." British Journal of Dermatology 121(2): 161-174. <http://hdl.handle.net/2027.42/74262>en_US
dc.identifier.issn0007-0963en_US
dc.identifier.issn1365-2133en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74262
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2476168&dopt=citationen_US
dc.description.abstractKeratinocytes from involved psoriatic plaques (PP), uninvolved, clinically symptomless skin of psoriatic patients (PN) and normal healthy skin (NN) have been cultured in a low calcium serum free system for multiple passages. In this way, the keratinocytes were removed from microenvironmental factors present in the skin. While the basal rate of proliferation of the PP, PN and NN keratinocytes was not different, the PP cells produced more transforming growth factor-Α (TGF-Α) than NN cells, and the antiproliferative response of PP cells to gamma interferon (IFN-Γ), a product of activated T lymphocytes, was reduced. We studied IFN-Γ because it can inhibit the proliferation of NN keratinocytes, induce their differentiation and the appearance of two immunoregulatory cell surface molecules, HLA-DR and intercellular adherence molecule-1 (ICAM-1), and because in another epithelial cell system, epidermal growth factor (EGF) modulates IFN-Γ activity. The mean antiproliferative effects of IFN-Γ at 50,200, and 500 U/ml for the PP group (n=10) was less compared to the NN group (n=11); P < 0.001, while the PN group (n=5) had a less dramatic, but statistically significant, reduction in growth inhibition by IFN-Γ only at 200 and 500 U/ml compared to NN cells; P < 0.05 and P < 0.01, respectively. The amount of TGF-Α produced and secreted by PP keratinocytes from five different individuals was significantly greater than by NN keratinocyte cultures. In addition, IFN-Γ induced TGF-Α to a lesser extent in PP keratinocytes compared to NN keratinocyte cultures. Keratinocytes isolated from atopic dermatitis and SÉzary syndrome patients were similar to NN keratinocytes. In contrast to its differential effects of TGF-Α production and proliferation, IFN-Γ induced sinilar amounts of HLA-DR and ICAM-1 on PP, PN and NN keratinocytes. Thus, for the PP keratinocytes, there was a dissociaton between the antiproliferative and immunomodulatory effects of IFN-Γ. These results support our previous hypothesis that the hyperprolifertion and altered differentiation of keratinocytes in psoriatic plaques is linked to an altered responsiveness of the keratinocytes to IFN-Γ. Moreover, these results provide an in vitro correlate of our in vivo observation of increased TGF-Α levels in psoriatic plaques. A new pathophysiological model to understand psoriasis is proposed which integrates these observations involving IFN-Γ and TGF-Α. This experimental approach also provides a system to dissect biochemical pathways of pathophysiological importance for keratinocyte hyperproliferation in psoriasis.en_US
dc.format.extent5209016 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1989 British Association of Dermatologistsen_US
dc.titleDecreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-Α production in keratinocytes cultured from psoriatic lesionsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartments of Pathology University of Michigan Medical Center, Ann Arbor, Michigan, U.S.A.en_US
dc.contributor.affiliationum* Dermatology, University of Michigan Medical Center, Ann Arbor, Michigan, U.S.A.en_US
dc.identifier.pmid2476168en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74262/1/j.1365-2133.1989.tb01795.x.pdf
dc.identifier.doi10.1111/j.1365-2133.1989.tb01795.xen_US
dc.identifier.sourceBritish Journal of Dermatologyen_US
dc.identifier.citedreferenceWeinstein GD, Frost P. Abnormal cell proliferation in psoriasis. J Invest Dermatol 1968; 50: 254 – 9.en_US
dc.identifier.citedreferenceKrueger GG, Bergstresser PR, Lowe NJ et al. Psoriasis. J Am Acad Dermatol 1984; 11: 937 – 47.en_US
dc.identifier.citedreferenceNickoloff BJ. New strategies for psoriasis therapy. Cutis 1986; 37: 421 – 3.en_US
dc.identifier.citedreferenceHarper RA, Rispler J, Urbanek WR. DNA synthesis among uninvolved and involved psoriatic epidermal cells and normal epidermal cells in vitro. J Invest Dermatol 1978; 70: 254 – 6.en_US
dc.identifier.citedreferenceSaiag P, Coulomb B, Lebreton C et al. Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro. Science 1985; 230: 669 – 72.en_US
dc.identifier.citedreferenceDavison P, Liu SC, Karasek M. Limitations in the use of 3 H-thymidine incorporation into DNA as an indicator of epidermal keratinocyte proliferation in vitro. Cell Tissue Kinet 1979; 12: 605 – 15.en_US
dc.identifier.citedreferenceKragballe K, Desjarlais L, Marcelo CL. Increased DNA synthesis of uninvolved psoriatic epidermis is maintained in vitro. Br J Dermatol 1985; 112: 263 – 70.en_US
dc.identifier.citedreferenceFlaxman BA, Chopra DP. Cell cycle of normal and psoriatic epidermis in vitro. J Invest Dermatol 1972; 59: 102 – 5.en_US
dc.identifier.citedreferenceChopra DP, Flaxman BA. Comparative proliferative kinetics of cells from normal human epidermis and benign epidermal hyperplasia (psoriasis) in vitro. Cell Tissue Kinet 1974; 7: 69 – 75.en_US
dc.identifier.citedreferenceBaden HP, Kubilus J, MacDonald MJ. Normal and psoriatic keratinocytes and fibroblasts compared in culture. J Invest Dermatol 1981; 76: 53 – 5.en_US
dc.identifier.citedreferenceLiu SCC, Parsons CS. Serial cultivation of epidermal keratinocytes from psoriatic plaques. J Invest Dermatol 1983; 81: 54 – 61.en_US
dc.identifier.citedreferenceNickoloff BJ. Lymphocyte-keratinocyte interactions mediated through interferon: New observations relevant to psoriasis. Cutis 1984; 34: 445 – 6.en_US
dc.identifier.citedreferenceBasham TY, Nickoloff BJ, Merigan TC, Morhenn VB. Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes. J Invest Dermatol 1984; 83: 88 – 92.en_US
dc.identifier.citedreferenceNickoloff BJ, Basham TY, Merigan TC, Morhenn VB. Antiproliferative effects of recombinant alpha and gamma interferons on cultured human keratinocytes. Lab Invest 1984; 51: 697 – 701.en_US
dc.identifier.citedreferenceNickoloff BJ, Mahrle G, Morhenn VB. Ultrastructural effects of recombinant gamma interferon on cultured human keratinocytes. Ultrastruct Pathol 1986; 10: 17 – 21.en_US
dc.identifier.citedreferenceBjerke JR, Livden JK, DegrÉ M. Interferon in suction blister fluid from psoriatic lesions. Br J Dermatol 1983; 108: 295 – 9.en_US
dc.identifier.citedreferenceZullo JN, Cochran BH, Huang AS, Stiles CD. Platelet derived growth factor and double stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells. Cell 1985; 43: 793 – 800.en_US
dc.identifier.citedreferenceNickoloff BJ. Interferons and Psoriasis—1987 Perspective. Dermatologica 1987; 175: 1 – 4.en_US
dc.identifier.citedreferenceTodd I, Pujol-Borrell R, Belfiore A, Bottazzo GF. Thyrocyte HLA class II expression and regulation in relation to thyroid autoimmunity. Acta Endocrinol (Copenh) 1987; 281: ( Suppl ) 27 – 34.en_US
dc.identifier.citedreferenceGottlieb AB, Chang CK, Posnett DN et al. Detection of transforming growth factor Α in normal, malignant, and hyperproliferative human keratinocytes. J Exp Med 1988; 167: 670 – 7.en_US
dc.identifier.citedreferenceElder JT, Fisher GJ, Lindguist PB et al. Over expression of TGF-Α, but not TGF-Β, in psoriasis epidermis: Potential role of phospholipase C. Science 1989; 243: 811 – 4.en_US
dc.identifier.citedreferenceCoffey RJ, Derynck R, Wilcox JN et al. Production and auto-induction of transforming growth factor-Α in human keratinocytes. Nature 1987; 328: 817 – 820.en_US
dc.identifier.citedreferenceGriffiths CEM, Voorhees JJ, Nickoloff BJ. Gamma interferon induces different keratinocyte cellular patterns of expression of HLA-DR and DQ and intercellular adhesion molecule-1 (ICAM-1) antigens. Br J Dermatol 1989; 120: 1 – 8.en_US
dc.identifier.citedreferenceAscoli M. Internalization and degradation of receptor-bound human choriogonadotrophin in Leydig tumor cells. J Biol Chem 1982; 257: 13306 – 11.en_US
dc.identifier.citedreferenceManiatis T, Fritsch EF, Sambrook J. Extraction, purification and analysis of mRNA from eukaryotic cells. In: Molecular Cloning, a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982; 188 – 209.en_US
dc.identifier.citedreferenceThompson CB, Challoner PB, Neiman PE, Groudine M. Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature 1985; 314: 363 – 6.en_US
dc.identifier.citedreferenceFeinberg AP, Volgelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6 – 13.en_US
dc.identifier.citedreferenceGupta AK, Fisher GJ, Elder JT et al. Sphingosine inhibits phorbol ester-induced inflammation, ornithine decarboxylase activity, and activation of protein kinase C in mouse skin. J Invest Dermatol 1988; 11: 486 – 91.en_US
dc.identifier.citedreferenceDugaiczyk A, Haron JA, Stone EM et al. Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde 3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle. Biochem 1983; 22: 1605 – 13.en_US
dc.identifier.citedreferenceO'Keefe EJ, Chiu ML. Stimulation of thymidine incorporation in keratinocytes by insulin, epidermal growth factor, and placental extract: Comparison with cell number to assess growth. J Invest Dermatol 1988; 90: 2 – 7.en_US
dc.identifier.citedreferenceGilchrist BA. In vitro assessment of keratinocyte aging. J Invest Dermatol 1983; 81: 1845 – 95.en_US
dc.identifier.citedreferenceGriffin TD, Lattanand A, VanScott EJ. Clinical and histologic heterogeneity of psoriatic plaques: therapeutic relevance. Arch Dermatol 1988; 124: 216 – 20.en_US
dc.identifier.citedreferenceBarrandon Y, Green H. Three cloncal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci (USA) 1987; 84: 2302 – 6.en_US
dc.identifier.citedreferenceFarber EM, Nall ML. The natural history of psoriasis in 5600 patients. Dermatologica 1974; 148: 1 – 18.en_US
dc.identifier.citedreferenceFarber EM, Nall ML, Watson W. Natural history of psoriasis in 61 twin pairs. Arch Dermatol 1974; 109: 207 – 11.en_US
dc.identifier.citedreferenceBaker BS, Powles AV, Valdimarsson H et al. An altered response by psoriatic keratinocytes to gamma interferon. Scand J Immunol 1988; 28: 735 – 40.en_US
dc.identifier.citedreferenceNanney LB, Stoscheck CM, Magid M, King LE. Altered 125 I-epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol 1986; 86: 260 – 5.en_US
dc.identifier.citedreferenceGastl G, Marth C, Leiter E et al. Effects of human recombinant Α 2 -interferon and Γ-interferon on human breast cancer cell lines: Dissociation of antiproliferative activity and induction of HLA-DR antigen expression. Canc Res 1985; 45: 2957 – 61.en_US
dc.identifier.citedreferenceCox AJ, Watson W. Histologic variations in lesions of psoriasis. Arch Dermatol 1972; 106: 503 – 603.en_US
dc.identifier.citedreferenceHeadington JT, Gupta AK, Goldfarb MT, Voorhees JJ. Downsized follicles and sebaceous gland atrophy characterize psoriasis of the scalp: New findings after morphometric studies. J Cut Path 1988; 15: 313.en_US
dc.identifier.citedreferenceNickoloff BJ, Mitra RS. Pretreatment of keratinocytes with gamma interferon dramatically reduces binding by epidermal growth factor. Clin Res 1988; 36: 908.en_US
dc.identifier.citedreferenceValdimarsson H, Baker BS, Jonsdottir I, Fry L. Psoriasis: A disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol Today 1987; 7: 256 – 9.en_US
dc.identifier.citedreferenceMorhenn VB, Nickoloff BJ. The effect of gamma interferon on psoriatic keratinocytes. In: Proc IV Int. Symp Psoriasis. ( Farber EM, Nall L, Morhenn VB, Jacobs PH, eds ), NY: Elsevier, 1987; 355.en_US
dc.identifier.citedreferenceMorhenn VB, Pregerson-Rodan K, Mullen RH et al. Use of recombinant interferon gamma administered intramuscularly for the treatment of psoriasis. Arch Dermatol 1987; 123: 1633 – 7.en_US
dc.identifier.citedreferenceNickoloff BJ, Lewinsohn D, Butcher E et al. Recombinant gamma interferon increases binding of peripheral blood mononuclear leukocytes and a Leu3 + T lymphocyte clone to cultured keratinocytes and to a malignant cutaneous squamous carcinoma cell line that is blocked by antibody against the LFA-1 molecule. J Invest Dermatol 1988; 90: 17 – 22.en_US
dc.identifier.citedreferenceNickoloff BJ. Role of interferon gamma in cutaneous trafficking of lymphocytes with emphasis on molecular and cellular adhesion events. Arch Dermatol 1988; 124: 1835 – 43.en_US
dc.identifier.citedreferenceSchulze HJ, Mahrle G. Effect of interferons (rIFN-alpha 2, rIFN-gamma) on DNA synthesis and HLA-DR expression in psoriasis. Arch Dermatol Res 1986; 278: 416 – 18.en_US
dc.identifier.citedreferenceKaplan G, Nusrat A, Sarno EN et al. Cellular response to the intradermal injection of recombinant human Γ-interferon in lepromatous leprosy patients. Am J Pathol 1987; 128: 345 – 53.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.